These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38950157)

  • 1. Cheaper is not always better: Drug shortages in the United States and a value-based solution to alleviate them.
    Hernandez I; Sullivan SD; Hansen RN; Fendrick AM
    J Manag Care Spec Pharm; 2024 Jul; 30(7):719-727. PubMed ID: 38950157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Evolution of Supply and Demand in Markets for Generic Drugs.
    Frank RG; McGuire TG; Nason I
    Milbank Q; 2021 Sep; 99(3):828-852. PubMed ID: 34075623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical drug shortages: implications for emergency medicine.
    Mazer-Amirshahi M; Pourmand A; Singer S; Pines JM; van den Anker J
    Acad Emerg Med; 2014 Jun; 21(6):704-11. PubMed ID: 25039558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generic drug prices and policy in Australia: room for improvement? a comparative analysis with England.
    Mansfield SJ
    Aust Health Rev; 2014 Feb; 38(1):6-15. PubMed ID: 24480618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do generics offer significant savings to the UK National Health Service?
    Kanavos P
    Curr Med Res Opin; 2007 Jan; 23(1):105-16. PubMed ID: 17257472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Problem of Limited-Supply Agreements for Medicare Price Negotiation.
    Gabriele SME; Feldman WB
    JAMA; 2023 Oct; 330(13):1223-1224. PubMed ID: 37713185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International experiences of promoting generics use and its implications to China.
    Sun J
    J Evid Based Med; 2013 May; 6(2):74-80. PubMed ID: 23829799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How the US Food and Drug Administration can solve the prescription drug shortage problem.
    Schweitzer SO
    Am J Public Health; 2013 May; 103(5):e10-4. PubMed ID: 23488502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reference pricing of pharmaceuticals for Medicare: evidence from Germany, The Netherlands, and New Zealand.
    Danzon PM; Ketcham JD
    Front Health Policy Res; 2004; 7():1-54. PubMed ID: 15612334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causes of drug shortages in the legal pharmaceutical framework.
    De Weerdt E; Simoens S; Hombroeckx L; Casteels M; Huys I
    Regul Toxicol Pharmacol; 2015 Mar; 71(2):251-8. PubMed ID: 25591547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specialty pharmacies and other restricted drug distribution systems: financial and safety considerations for patients and health-system pharmacists.
    Kirschenbaum BE
    Am J Health Syst Pharm; 2009 Dec; 66(24 Suppl 7):S13-20. PubMed ID: 19966075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent drug shortages jeopardise patient safety in the USA.
    Furlow B
    Lancet Respir Med; 2015 Mar; 3(3):182-3. PubMed ID: 25732929
    [No Abstract]   [Full Text] [Related]  

  • 13. Indication-specific pricing of pharmaceuticals in the US healthcare system.
    Pearson SD; Dreitlein WB; Henshall C; Towse A
    J Comp Eff Res; 2017 Jul; 6(5):397-404. PubMed ID: 28699779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic and technological drivers of generic sterile injectable drug shortages.
    Woodcock J; Wosinska M
    Clin Pharmacol Ther; 2013 Feb; 93(2):170-6. PubMed ID: 23337525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Market Competition and Prices of Generic Topical Dermatology Drugs.
    Li DG; Joyce C; Mostaghimi A
    JAMA Dermatol; 2018 Dec; 154(12):1441-1446. PubMed ID: 30383117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of European pharmaceutical price regulation on generic price competition: a review.
    Puig-Junoy J
    Pharmacoeconomics; 2010; 28(8):649-63. PubMed ID: 20515079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-cost generic drugs--implications for patients and policymakers.
    Alpern JD; Stauffer WM; Kesselheim AS
    N Engl J Med; 2014 Nov; 371(20):1859-62. PubMed ID: 25390739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Medicaid excess payments from alleged price manipulation of generic lorazepam.
    Bian B; Gorevski E; Kelton CM; Guo JJ; Martin Boone JE
    J Manag Care Pharm; 2012 Sep; 18(7):506-15. PubMed ID: 22971204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.
    Kesselheim AS; Avorn J; Sarpatwari A
    JAMA; 2016 Aug 23-30; 316(8):858-71. PubMed ID: 27552619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Australian drugs scheme threatens free-trade talks.
    Fickling D
    Lancet; 2004 Jan; 363(9405):299. PubMed ID: 14753208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.